Orris

Rheumatism interpretation

Reading File
Finding Sources
Searching PubMed

rheumatic diseases

Searching the Web

rheumatism definition rheumatic diseases terminology

Rheumatism is a broad, non-specific older term for pain, stiffness, or inflammation involving the joints, muscles, tendons, ligaments, or connective tissues. It is not a single diagnosis.
It may refer to many different rheumatic and musculoskeletal diseases, including:
  • Osteoarthritis: wear-related joint pain, often worse with activity.
  • Rheumatoid arthritis: autoimmune inflammatory arthritis, often with swollen small joints and prolonged morning stiffness.
  • Gout: sudden, intensely painful swollen joint due to urate crystals.
  • Fibromyalgia: widespread pain with fatigue and sleep problems, without joint inflammation.
  • Polymyalgia rheumatica: shoulder and hip stiffness in older adults.
  • Tendonitis/bursitis: inflammation around a joint.
  • Less commonly, connective-tissue diseases such as lupus or scleroderma.
Modern clinicians usually avoid using “rheumatism” alone because it does not identify the underlying cause. Rheumatic diseases can affect joints but may also affect muscles, bones, skin, eyes, lungs, kidneys, or blood vessels, as described in the ACR/EULAR public definition.
Seek medical assessment promptly if there is a hot, red, markedly swollen joint; fever; inability to bear weight; new rash; chest pain; or sudden severe symptoms. For ongoing pain or morning stiffness lasting more than a few weeks, a clinician or rheumatologist can clarify the specific diagnosis.

Rheumatic heart disease interpretation

Reading File
Finding Sources
Finding Sources
Searching PubMed

rheumatic heart disease

Searching the Web

WHO rheumatic heart disease fact sheet diagnosis treatment prevention

Rheumatic heart disease (RHD) means permanent damage to one or more heart valves caused by prior acute rheumatic fever.

How it develops

  1. A child or young person gets an untreated or inadequately treated group A streptococcal throat infection.
  2. In some people, the immune system reacts abnormally a few weeks later, causing acute rheumatic fever.
  3. Repeated attacks can inflame and scar the heart valves, producing RHD over time.
It is not an active infection of the heart, and it is not contagious. The original strep infection can spread, but the later valve disease cannot.

Which valve is commonly affected?

The mitral valve is affected most often. Damage may cause:
  • Mitral stenosis: a narrowed valve that obstructs blood flow
  • Mitral regurgitation: a leaking valve
  • Sometimes aortic-valve involvement

Possible features

Early disease may have no symptoms. More advanced disease may cause:
  • Breathlessness, especially on exertion or lying flat
  • Tiredness and reduced exercise capacity
  • Palpitations or irregular heartbeat, such as atrial fibrillation
  • Leg/ankle swelling
  • Chest discomfort, dizziness, or fainting
  • Stroke risk when atrial fibrillation or clots occur

Interpretation in a report

If an echocardiogram or medical report states “rheumatic heart disease,” it generally indicates valve changes that appear consistent with previous rheumatic fever. The report should specify the valve, whether there is stenosis or regurgitation, and whether severity is mild, moderate, or severe.

Management

Management depends on the valve lesion and severity. It can include:
  • Regular cardiology follow-up and echocardiography
  • Long-term antibiotic prophylaxis to prevent recurrent rheumatic fever when indicated
  • Medicines for heart failure, rhythm control, or anticoagulation when needed
  • Valve repair or replacement for severe disease
The WHO RHD guidance emphasizes early treatment of suspected group A streptococcal infections and secondary antibiotic prophylaxis to prevent recurrent rheumatic fever and further valve damage. Established valve scarring is generally permanent, though symptoms and complications can often be managed; severe valve disease may require repair or replacement, as summarized in the WHO fact sheet.
Seek urgent care for severe breathlessness, fainting, chest pain, coughing pink froth, or new stroke-like symptoms.

Find the latest guidelines for rheumatic heart disease

Reading File
Reading File
Searching the Web

2024 WHO guideline prevention diagnosis rheumatic fever rheumatic heart disease recommendations PDF

Searching the Web

rheumatic heart disease guideline 2025 2026 clinical practice guideline

Searching PubMed

"rheumatic heart disease" AND guideline

Finding Sources
Reading Web Page

https://iris.who.int/server/api/core/bitstreams/fbd835e1-b9b…

Reading Web Page

https://www.escardio.org/guidelines/clinical-practice-guidel…

Reading Article

PMID: 36428195

Latest rheumatic heart disease guidelines

1. WHO 2024 guideline

The most recent dedicated global guideline is the WHO Guideline on the Prevention and Diagnosis of Rheumatic Fever and Rheumatic Heart Disease (2024). It focuses on preventing rheumatic fever and detecting RHD early.
Key recommendations include:
  • Treat suspected group A streptococcal infections appropriately to prevent first episodes of acute rheumatic fever.
  • Give long-term antibiotic secondary prophylaxis to people diagnosed with rheumatic fever or RHD to prevent recurrent rheumatic fever and added valve injury.
  • Intramuscular benzathine benzylpenicillin is the preferred first-line prophylaxis approach when suitable.
  • In moderate- or high-prevalence settings, offer echocardiographic screening to children and adolescents aged 5-19 years to identify early, symptom-free RHD.
  • Give antibiotic prophylaxis to children and adolescents meeting minimum echocardiographic criteria for RHD, even if disease was detected through screening.
  • For adults, particularly those with advanced disease, prophylaxis decisions should incorporate individual risk and shared decision-making.
The guideline does not cover every aspect of advanced valve intervention, so local protocols and valve-disease guidelines should be used alongside it.

2. ESC/EACTS 2025 valvular heart disease guideline

For established valve damage, the current major guidance is the 2025 ESC/EACTS Guideline for Valvular Heart Disease. It updates the 2021 version and applies to rheumatic mitral stenosis, mitral regurgitation, mixed valve lesions, atrial fibrillation, heart failure, pregnancy-related decisions, and timing of catheter or surgical intervention.
Key practical themes:
  • Define valve anatomy and severity with high-quality echocardiography.
  • Refer complex cases to a Heart Valve Centre/Heart Team.
  • Consider valve intervention when stenosis or regurgitation is severe, symptomatic, causing pulmonary hypertension, atrial fibrillation, ventricular effects, or other complications.
  • Choose percutaneous balloon mitral intervention versus surgery based on valve anatomy, thrombus/regurgitation, coexisting valve disease, and patient factors.

3. Echocardiography guidance

The American Society of Echocardiography 2023 recommendations give RHD-specific imaging guidance: Pandian et al., 2023, PMID 36428195. They emphasize echocardiography for diagnosis, severity assessment, intervention planning, and follow-up. Typical rheumatic features include leaflet thickening, restricted leaflet movement, commissural fusion, and subvalvular disease, most commonly involving the mitral valve.

Bottom line

  • WHO 2024 is the latest dedicated RHD guideline for prevention, screening, diagnosis, and antibiotic prophylaxis.
  • ESC/EACTS 2025 is the current major guideline for management of the resulting valvular heart disease.
  • ASE 2023 is a useful focused standard for echocardiographic evaluation.
Antibiotic choice, injection interval, and total duration of secondary prophylaxis must be individualized by a cardiologist or infectious-disease/rheumatic-fever program, especially if there is established valve disease, pregnancy, penicillin allergy, anticoagulant use, or atrial fibrillation.
This is a shared conversation. Sign in to Orris to start your own chat.